Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Mar 28, 2024; 30(12): 1714-1726
Published online Mar 28, 2024. doi: 10.3748/wjg.v30.i12.1714
Table 2 Comparison between the higher hematocrit group and the lower hematocrit group
Characteristics
Higher hematocrit (n = 2166)
Lower hematocrit (n = 2092)
P value
Hematocrit42.1 ± 3.032.2 ± 4.4< 0.01a
Age, yr61.2 ± 11.364.6 ± 12.7< 0.01a
Sex< 0.01a
    Male1580 (72.9)933 (44.6)
    Female586 (27.1)1159 (55.4)
BMI, kg/m223.2 ± 3.122.2 ± 3.2< 0.01a
Smoking1023 (47.2)594 (28.4)< 0.01a
Drinking839 (38.7)476 (22.8)< 0.01a
Hypertension540 (24.9)573 (27.4)0.068
T2DM220 (10.2)321 (15.3)< 0.01a
CHD68 (3.1)113 (5.4)< 0.01a
Open surgery222 (10.2)341 (16.3)< 0.01a
Tumor location< 0.01a
    Colon782 (36.1)1226 (58.6)
    Rectum1384 (63.9)866 (41.4)
TNM stage< 0.01a
    I485 (22.4)318 (15.2)
    II847 (39.1)900 (43.0)
    III750 (34.6)764 (36.5)
    IV84 (3.9)110 (5.3)
Tumor size< 0.01a
    < 5 cm1415 (65.3)1040 (49.7)
    ≥ 5 cm751 (34.7)1052 (50.3)
Operation time (min)228.1 ± 85.4226.8 ± 81.10.593
Blood loss (mL)96.3 ± 138.0107.6 ± 157.10.012a
Hospital stay (d)11.0 ± 7.511.6 ± 9.80.016a
Overall complications419 (19.3)519 (24.8)< 0.01a
Major complications53 (2.4)49 (2.3)0.823